Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl. [electronic resource]
Producer: 20060411Description: 607-14 p. digitalISSN:- 0344-5704
- Adamantane -- analogs & derivatives
- Animals
- Antineoplastic Agents -- pharmacokinetics
- Blood Proteins -- metabolism
- Chromatography, High Pressure Liquid
- Dogs
- Drug Evaluation, Preclinical
- Drug Stability
- Humans
- Hydroquinones -- pharmacokinetics
- Injections, Intraperitoneal
- Injections, Intravenous
- Metabolic Clearance Rate
- Mice
- Proto-Oncogene Proteins c-abl -- antagonists & inhibitors
- Proto-Oncogene Proteins c-bcr -- antagonists & inhibitors
- Rats
- Rats, Inbred F344
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.